Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 15,600 IMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | ImageneBio, Inc. (IMA) | Grant/Award | 15,600 | n/a |
| Jun 10, 2026 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 38,000 | n/a |
| Apr 23, 2026 | Prelude Therapeutics Inc (PRLD) | Purchase | 1,689,189 | $7.50M |
| Apr 16, 2026 | ImageneBio, Inc. (IMA) | Purchase | 336,603 | n/a |
| Jul 30, 2025 | ImageneBio, Inc. (IMA) | Exercise/Conversion | 379 | n/a |
| Jun 13, 2025 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 38,000 | n/a |
| Jun 20, 2024 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 27,200 | n/a |
| Jun 18, 2024 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 23,500 | n/a |
| Jun 10, 2024 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 17,520 | n/a |
| Jun 10, 2024 | Third Harmonic Bio, Inc. (THRD) | Grant/Award | 20,000 | n/a |